IBDEI1KH ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26197,2)
 ;;=^5008725
 ;;^UTILITY(U,$J,358.3,26198,0)
 ;;=K70.10^^127^1272^13
 ;;^UTILITY(U,$J,358.3,26198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26198,1,3,0)
 ;;=3^Alcoholic Hepatitis w/o Ascites
 ;;^UTILITY(U,$J,358.3,26198,1,4,0)
 ;;=4^K70.10
 ;;^UTILITY(U,$J,358.3,26198,2)
 ;;=^5008785
 ;;^UTILITY(U,$J,358.3,26199,0)
 ;;=K73.0^^127^1272^34
 ;;^UTILITY(U,$J,358.3,26199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26199,1,3,0)
 ;;=3^Chronic Persistent Hepatitis NEC
 ;;^UTILITY(U,$J,358.3,26199,1,4,0)
 ;;=4^K73.0
 ;;^UTILITY(U,$J,358.3,26199,2)
 ;;=^5008811
 ;;^UTILITY(U,$J,358.3,26200,0)
 ;;=N12.^^127^1272^104
 ;;^UTILITY(U,$J,358.3,26200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26200,1,3,0)
 ;;=3^Tubulo-Interstitial Nephritis
 ;;^UTILITY(U,$J,358.3,26200,1,4,0)
 ;;=4^N12.
 ;;^UTILITY(U,$J,358.3,26200,2)
 ;;=^5015575
 ;;^UTILITY(U,$J,358.3,26201,0)
 ;;=N30.90^^127^1272^42
 ;;^UTILITY(U,$J,358.3,26201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26201,1,3,0)
 ;;=3^Cystitis w/o Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,26201,1,4,0)
 ;;=4^N30.90
 ;;^UTILITY(U,$J,358.3,26201,2)
 ;;=^5015642
 ;;^UTILITY(U,$J,358.3,26202,0)
 ;;=N30.91^^127^1272^41
 ;;^UTILITY(U,$J,358.3,26202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26202,1,3,0)
 ;;=3^Cystitis w/ Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,26202,1,4,0)
 ;;=4^N30.91
 ;;^UTILITY(U,$J,358.3,26202,2)
 ;;=^5015643
 ;;^UTILITY(U,$J,358.3,26203,0)
 ;;=N70.92^^127^1272^81
 ;;^UTILITY(U,$J,358.3,26203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26203,1,3,0)
 ;;=3^Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,26203,1,4,0)
 ;;=4^N70.92
 ;;^UTILITY(U,$J,358.3,26203,2)
 ;;=^5015807
 ;;^UTILITY(U,$J,358.3,26204,0)
 ;;=N73.9^^127^1272^51
 ;;^UTILITY(U,$J,358.3,26204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26204,1,3,0)
 ;;=3^Female Pelvic Inflammatory Disease,Unspec
 ;;^UTILITY(U,$J,358.3,26204,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,26204,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,26205,0)
 ;;=N72.^^127^1272^69
 ;;^UTILITY(U,$J,358.3,26205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26205,1,3,0)
 ;;=3^Inflammatory Disease of Cervix Uteri
 ;;^UTILITY(U,$J,358.3,26205,1,4,0)
 ;;=4^N72.
 ;;^UTILITY(U,$J,358.3,26205,2)
 ;;=^5015812
 ;;^UTILITY(U,$J,358.3,26206,0)
 ;;=N76.0^^127^1272^12
 ;;^UTILITY(U,$J,358.3,26206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26206,1,3,0)
 ;;=3^Acute Vaginitis
 ;;^UTILITY(U,$J,358.3,26206,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,26206,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,26207,0)
 ;;=N76.1^^127^1272^105
 ;;^UTILITY(U,$J,358.3,26207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26207,1,3,0)
 ;;=3^Vaginitis,Subacute/Chronic
 ;;^UTILITY(U,$J,358.3,26207,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,26207,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,26208,0)
 ;;=L03.011^^127^1272^27
 ;;^UTILITY(U,$J,358.3,26208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26208,1,3,0)
 ;;=3^Cellulitis of Right Finger
 ;;^UTILITY(U,$J,358.3,26208,1,4,0)
 ;;=4^L03.011
 ;;^UTILITY(U,$J,358.3,26208,2)
 ;;=^5009019
 ;;^UTILITY(U,$J,358.3,26209,0)
 ;;=L03.012^^127^1272^20
 ;;^UTILITY(U,$J,358.3,26209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26209,1,3,0)
 ;;=3^Cellulitis of Left Finger
 ;;^UTILITY(U,$J,358.3,26209,1,4,0)
 ;;=4^L03.012
 ;;^UTILITY(U,$J,358.3,26209,2)
 ;;=^5009020
 ;;^UTILITY(U,$J,358.3,26210,0)
 ;;=L03.031^^127^1272^30
 ;;^UTILITY(U,$J,358.3,26210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26210,1,3,0)
 ;;=3^Cellulitis of Right Toe
 ;;^UTILITY(U,$J,358.3,26210,1,4,0)
 ;;=4^L03.031
 ;;^UTILITY(U,$J,358.3,26210,2)
 ;;=^5009025
